Clinical Trial Update: Post-Marketing Study to Assess the Safety & Efficacy of RenalGuard® Therapy for Prevention CSA-AKI [NA]

View source ↗

Summary

Post-marketing study to assess the safety and efficacy of RenalGuard therapy for preventing cardiac surgery-associated acute kidney injury; the study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Surgery-associated Acute Kidney Injury
• Kidney Injury

Drugs mentioned

• RenalGuard

Snippet

Sponsor: CardioRenal Systems, Inc. | Conditions: AKI - Acute Kidney Injury, Cardiac Surgery Associated - Acute Kidney Injury | NA | Status: ACTIVE_NOT_RECRUITING